Skip to content
It's time to build
Nav Opener
  • Portfolio
  • Team
  • Focus Areas
    • American Dynamism
    • Bio + Health
    • Cultural Leadership Fund
    • Consumer
    • Crypto
    • Enterprise
    • Fintech
    • Games
    • Growth
    • Talent x Opportunity
  • Content
    Topics
    • Bio + Health
    • Consumer
    • Creator Economy
    • Marketplaces
    • Gaming & Social
    • Fintech
    • Enterprise & SaaS
    • Security & Privacy
    • Cryptocurrencies & Blockchains
    Type
    • Articles
    • Video
    • Podcasts
    • Newsletters
  • About
  • Jobs
  • Newsletters
Close

Jeffrey Low

  • LinkedIn

Latest Posts

Disruptive Innovation: The Role of Hospitals, Integration, and the Value-Added Process

by Jeffrey Low, Richard Menger, and Gregory Mundis
  • bio + health
  • disruption theory & practice
  • book launches (and book pods)
  • healthcare

a16z Podcast: Shifting Risk Mindsets, From Tech to Bio

by Jorge Conde, Vijay Pande, and Jeffrey Low
  • bio + health
  • building a bio company
  • go-to-market
  • hallway conversations
  • healthcare
  • videos

a16z Video: Shifting Risk Mindsets, from Tech to Bio

by Jorge Conde, Vijay Pande, and Jeffrey Low
  • bio + health
  • go to market
  • hallway conversations
  • healthcare
  • videos
  • when science becomes engineering

16 Pitfalls to Avoid When Building a Computational Therapeutics Company

by Jeffrey Low, Vijay Pande, and Jorge Conde
  • bio + health
  • go to market
  • building a bio company
  • drug development
  • glossaries & terms to know
  • healthcare
  • listicles

From @JeffreyLowMD

Jeffrey Low@JeffreyLowMD

Proud of a great team and 2021 for Novo Growth -$270m deployed -11 new investments -$1.2b in portfolio value -Highlights and themes 1. AI designed drugs into clinic 2. COVID vaccine manufacturing 3. Precision oncology 4. Real world data 5. Sustainable materials https://t.co/fNxoKIoHqJ

Jeffrey Low@JeffreyLowMD

Going to Miami for the first time. Who should I meet with in biotech and healthcare?

Jeffrey Low@JeffreyLowMD

Many startups have not updated the once lofty valuations of their public comps in their decks

Software is eating the world
© 2023 Andreessen Horowitz
Software is eating the world
    • Twitter
    • Simplecast
  • Contact
  • Jobs
  • Briefings
  • Terms of Use & Privacy
  • Disclosures
  • Conduct
  • Who We Are